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Abstract
Bacterial hyaluronidases, enzymes capable of breaking down hyaluronate, are produced by a number of pathogenic Gram-positive
bacteria that initiate infections at the skin or mucosal surfaces. Since reports of the hyaluronidases first appeared, there have been numerous
suggestions as to the role of the enzyme in the disease process. Unlike some of the other more well studied virulence factors, much of the
information on the role of hyaluronidase is speculative, with little or no data to substantiate proposed roles. Over the last 5 years, a number
of these enzymes from Gram-positive organisms have been cloned, and the nucleotide sequence determined. Phylogenetic analysis, using the
deduced amino acid sequences of the Gram-positive hyaluronidases, suggests a relatedness among some of the enzymes. Molecular advances
may lead to a more thorough understanding of the role of hyaluronidases in bacterial physiology and pathogenesis. ß 2000 Federation of
European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Many pathogenic bacteria produce extracellular prod-
ucts that have tissue-damaging e¡ects. Some of the diverse
armamentarium of products from pathogenic bacteria
serve as virulence factors in the pathogenesis of disease
by facilitating the spread of bacteria or toxins through
tissues; these are commonly referred to as spreading fac-
tors. For many years, the term hyaluronidase has been
synonymous with spreading factors. Although all extra-
cellular hyaluronidases are probably spreading factors, not
all spreading factors are hyaluronidases. Hyaluronidase is
a general term used to describe enzymes that are able to
breakdown the substrate hyaluronate (hyaluronic acid, hy-
aluronan), however, some of these enzymes are also able
to cleave chondroitin sulfate [1], albeit at a slower rate.
The hyaluronidases can be subdivided into three types [1].
Hyaluronate-4-glycanohydrolases (EC 3.2.1.35) are the
testicular-type hyaluronidases found in mammalian sper-
matozoa, lysosomes and the venoms of various insects and
snakes. The second group are hyaluronate-3-glycanohy-
drolases (EC 3.2.1.36) produced by leeches and some
hookworms. Both of these groups of hyaluronidases de-
grade hyaluronate with the formation of tetrasaccharides
as the end product. The third group, the bacterial hyal-
uronidases or hyaluronate lyases (EC 4.2.2.1 or EC
4.2.99.1), act as endo-N-acetylhexosaminidases by elimina-
tion across the L-1-4 linkage (Fig. 1). Unlike the other
hyaluronidases, the products of hyaluronate lyases are un-
saturated disaccharides. These hyaluronidases are the fo-
cus of this review. Other polysaccharide lyases and a more
detailed examination of the mechanisms of action have
been the subject of other reviews [1,2] and will not be
addressed here.
Hyaluronate is a linear unsulfated glycosaminoglycan
polymer, with an average molecular mass greater than
10 000. The polymer is made up of alternating N-acetyl-
glucosamine and glucuronic acid residues linked by glyco-
sidic bonds (Fig. 1), but unlike other glycosaminoglycans,
it lacks a covalently linked peptide [3]. Hyaluronate is
found in many body tissues and £uids of higher organisms
such as umbilical cord, synovial £uid, cartilage, brain,
muscle, and is a major component of the extracellular
matrix especially in soft connective tissue [3] ; 50% of the
hyaluronate in the body is found in the skin. It is also
present in high concentrations in rooster combs and is
produced by certain bacteria such as the streptococci [3].
The hyaluronate isolated from all these various sources
has an identical chemical structure.
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2. Organisms producing hyaluronidase
A wide variety of microorganisms produce enzymes ca-
pable of degrading hyaluronate. Enzymes produced by the
Gram-negative organisms are periplasmic rather than
being excreted to the extracellular milieu, and so are less
likely to play a role in pathogenesis. Some of these en-
zymes are chondroitin lyases, as they are also capable of
degrading substrates such as chondroitin sulfate. Chon-
droitinase activity has been reported in the genera Aero-
monas, Vibrio, Beneckea and Proteus. Bacteroides fragilis,
Bacteroides vulgatus, Bacteroides ovatus, Bacteroides mela-
ninogenicus, Bacteroides asaccharolyticus and Fusobacte-
rium mortiferum are also reported to produce hyaluroni-
dase [2]. Treponema pallidum and Treponema pertenue,
both pathogens, produce a surface-associated hyaluronic
acid degrading enzyme, whereas the non-pathogenic Tre-
ponema denticola and Treponema vencentii do not produce
such an enzyme [4]. Anti-hyaluronidase sera, prepared
against bovine hyaluronidase, cross-reacted with both the
treponemal hyaluronidase and testicular hyaluronidase,
suggesting the treponemal hyaluronidase is similar to the
hyaluronate-4-glycanohydrolase type enzymes and may
not be a hyaluronate lyase; de¢nitive classi¢cation would
require isolation and characterization of the enzyme. Pro-
duction of hyaluronidase has also been reported in di¡er-
ent species of Candida, including C. albicans, C. tropicalis,
C. guillermondii, C. parapsilosis and C. krusei [5], although
the type of hyaluronidase is currently unknown.
Gram-positive organisms capable of producing hyal-
uronidase include various species of Streptococcus, Staphy-
lococcus, Peptostreptococcus, Propionibacterium, Strepto-
myces and Clostridium. Hyaluronidase production has
been reported in streptococci groups A, B, C and G [6],
as well as Streptococcus pneumoniae [7], members of the
viridans streptococci (Streptococcus intermedius and Strep-
tococcus constellatus) [8], Streptococcus dysgalactiae [9]
and Streptococcus uberis [10]. Among the staphylococci,
hyaluronidase production has been shown for pathogenic
strains of Staphylococcus aureus and Staphylococcus hyicus
subsp. hyicus [11]. Clostridium perfringens (Mu toxin) [12],
Clostridium di¤cile [13], Clostridium septicum (Q toxin) and
Clostridium chauvoei [14], all potential pathogens, produce
hyaluronidase. Two cutaneous Propionibacteria, Propioni-
bacterium acnes and Propionibacterium granulosum, pro-
duce hyaluronidase [15], with the enzyme from P. acnes
being characterized as a hyaluronate lyase. Streptomyces
hyalurolyticus, Streptomyces coelicolor and Streptomyces
griseus produce enzymes capable of degrading hyaluronate
[16]. A hyaluronidase puri¢ed and characterized from a
species of Peptostreptococcus also has activity against
chondroitin sulfate [17].
Most, if not all, of these Gram-positive genera capable
of elaborating hyaluronidase are able to cause infections
initiated at a mucosal or skin surface of either humans or
animals. The exceptions to this may be the Streptomyces ;
however, some Streptomyces species are capable of causing
infections, often by gaining access through skin abrasions.
Bacteriophages from two species of streptococci, Strep-
tococcus pyogenes [18] and Streptococcus equi [19], encode
hyaluronidase. A hyaluronic acid capsule can surround the
host cells of both of these phages; hence the bacteriophage
may require hyaluronidase for penetration of this capsular
material. No hyaluronidase activity was detected in the
extracellular milieu of either S. pyogenes or S. equi in-
fected with the temperate bacteriophages [18,19], suggest-
ing the enzymes may be part of the bacteriophage particle.
3. Sequence information
Eight complete bacterial hyaluronidase genes, and two
Fig. 1. Structure of hyaluronate and the products after eliminative cleavage by a bacterial hyaluronate lyase. The boxed region shows the repeating unit
of N-acetylglucosamine and glucuronic acid linked L-1-4 that constitutes hyaluronate. The repeating disaccharide is linked L-1-3 to the adjoining disac-
charide.
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bacteriophage genes, have had their nucleotide sequence
determined. The bacterial hyaluronidases, along with their
accession number, are from S. aureus (U21221) [20], Strep-
tococcus agalactiae (Y15903) [21], S. pneumoniae (L20670)
[7], S. griseus (AB028210), S. coelicolor (AL031124),
P. acnes (U15927) [22], C. perfringens (P26831) [12], Pro-
teus vulgaris (1095454) [23], along with a partial sequence
of the lyase from Bacteroides thetaiotaomicron (L42367)
[24]. Two sequenced bacteriophage hyaluronidases are
both derived from temperate phages that infect group A
streptococci (M19348 and U28144) [18].
Sequence analysis of the hyaluronidase genes provides
important information on the hyaluronidases. As the num-
ber of enzymes sequenced increases, more information will
become available that will be valuable in determining sim-
ilarities and di¡erences between the hyaluronidases.
Among those hyaluronidases of which the deduced amino
acid sequence is known, there is a wide variation in the
molecular masses. The streptococcal bacteriophage en-
zymes are the smallest, ranging between 36 and 40 kDa,
depending on the presence or absence of the collagenous
motif [18]. The deduced proteins of the other hyaluroni-
dases are much larger: S. agalactiae 121 kDa, S. pneumo-
niae 107 kDa, C. perfringens 114 kDa, S. aureus 92 kDa,
P. acnes 82 kDa, and the two Streptomyces sp. 77 and
84 kDa. Molecular masses of other (non-sequenced) hy-
aluronidases also vary considerably, ranging from 50 to
160 kDa [2].
Similarity alignments were conducted on these hyal-
uronidases as the sequence information became available.
Some enzymes show signi¢cant similarity, while little or
no homology is suggested among other hyaluronidases.
This raises the question, how closely related or how sim-
ilar are these enzymes? Fig. 2 shows the results of a phy-
logenetic analysis (AlignX, Informax, North Bethesda,
MD, USA) using the deduced amino acid sequences of
the bacterial hyaluronidases. Proteins from the Gram-pos-
itive organisms, with the exception of the clostridial hyal-
uronidase, appear to be related. Two subdivisions are
seen within the main group of Gram-positive hyaluroni-
dases. The S. agalactiae and S. pneumoniae enzymes ap-
pear closer to the S. aureus hyaluronidase than to the
Streptomyces enzymes. Similarly, the two Streptomyces hy-
aluronidases appear related, with the proteins appearing
more similar to the hyaluronidase from P. acnes than to
S. aureus. The Gram-negative hyaluronidases, the two
bacteriophage proteins, and the clostridial protein appear
more distantly related to the main group of Gram-positive
hyaluronidases. Not surprisingly, the two Gram-negative
proteins group together, as do the two phage hyaluroni-
dases.
The bacteriophage hyaluronidase genes show a high de-
gree of similarity; one major region of di¡erence is the
deletion (or addition) of a collagen-like Gly-X-Y region
[18,25]. Sequence homology alignments indicate that these
hyaluronidases show little homology to other hyaluroni-
dase genes in the databases, a point evident from the phy-
logenetic tree (Fig. 2). Marciel et al. [25] indicated sub-
stantial levels of allelic polymorphism among the
streptococcal bacteriophage hyaluronidases and suggested
that molecular variation was the result of recombination
processes. Such an analysis has not been carried out yet
with other hyaluronidases.
Among the remaining Gram-positive organisms, the hy-
aluronidases from S. aureus, S. agalactiae and S. pneumo-
niae show high degrees of similarity, with global similar-
ities above 65% and local similarities around 80%. In
terms of identical amino acids, the S. agalactiae and
S. pneumoniae appear more closely related than either is
to the S. aureus protein. The complete sequence of the
S. agalactiae hyaluronidase contains a promoter region,
ribosome binding site and signal peptide [21]. The S. au-
reus gene, although smaller than the S. agalactiae and
S. pneumoniae genes, may be complete as putative pro-
moter, ribosome binding site, and signal peptide regions
are present in the sequence [20]. Such is not the case with
the S. pneumoniae gene, which lacks a signal peptide [7].
Gase et al. [21] indicated that the initially reported se-
quence of the hyaluronidase gene from S. agalactiae was
not complete and suggested that the same is true for the
S. pneumoniae gene.
Like the S. aureus hyaluronidase, the P. acnes hyal-
Fig. 2. Phylogenetic tree based on the deduced amino acid sequences, showing the relatedness of the bacterial and phage hyaluronidases.
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uronidase gene sequence encodes a signal peptide [22],
suggesting a complete gene sequence. Analysis using the
sequence of a proposed hyaluronan binding site in P. acnes
(RKVASSSTK) [22] revealed similar sequences in all the
hyaluronidases from the Gram-positive bacteria. Although
the location of the conserved region within the protein
varies, all are in the more conserved C portion of the
protein. The enzymes from the bacteriophages do not ap-
pear to have a sequence similar to that of the proposed
hyaluronate binding site of Propionibacterium, perhaps
suggesting a di¡erent mechanism of action or at least a
di¡erent site of substrate binding.
4. Role in disease
Typically, during an infection of any type, the ground
substance secreted by connective tissues provides a mech-
anism of defense against infectious agents. The viscous
consistency of ground substance usually provides resis-
tance to penetration of infectious agents and their extra-
cellular products; however, some bacteria have adapted
ways to weaken the restraints of connective tissues.
Many pathogenic bacteria able to establish infections at
the mucosal or skin surface produce the enzyme hyal-
uronidase. Since hyaluronate is a major constituent of
the ground substance of most connective tissues, particu-
larly the skin, hyaluronidase may be an essential compo-
nent in enabling the spread of the pathogens from an
initial site of infection.
The ultimate products of hyaluronidase degradation of
hyaluronate are disaccharides (Fig. 1). These disaccharides
can be transported and metabolized intracellularly to sup-
ply needed nutrients for a pathogen as it replicates and
spreads. The role of providing nutrients for the cell may be
the main function of hyaluronidases in Gram-negative or-
ganisms [24]. In C. di¤cile, Seddon et al. [26] suggest that
hyaluronidase may play a role in releasing nutrients there-
by promoting establishment of the organism in the gut. A
strong association between the production of purulent ab-
scesses and hyaluronidase produced during infections with
organisms of the `Streptococcus milleri group' including
S. intermedius has been observed [27]. Isolates from inter-
nal abscesses and purulent lesions frequently produce hy-
aluronidase, and the deeper the abscess the higher the
frequency of hyaluronidase production. The authors sug-
gest that products of hyaluronidase degradation might be
utilizable as a nutrient source for the organism. In
S. intermedius [28] and B. thetaiotaomicron [24], the hyal-
uronidase, or proteins associated with the enzyme, are
induced in the presence of substrate. Addition of hyal-
uronate to growth media also results in increased levels
of hyaluronidase in group A streptococci [29]. Production
of the enzyme in response to the presence of substrate may
provide a way of regulating enzyme production to envi-
ronments (in vivo?) which enable the organism to prolif-
erate and use the substrate.
Perhaps the more signi¢cant result of the enzymatic
depolymerization of hyaluronate is a decrease in the vis-
cosity of the ground substance. Decreased viscosity results
in increased permeability of the connective tissues, and
potentially increased spread of microorganisms and toxins
through the connective tissues.
C. perfringens, the causative agent of gas gangrene, pro-
duces many extracellular proteins during an infection that
are potential virulence factors. One of these, the Mu toxin,
is a hyaluronidase that by itself is a non-lethal toxin of
C. perfringens. However, the enzyme facilitates the spread
of the major tissue-damaging K-toxin, thereby potentiating
its cytolytic activity [12]. The decreased viscosity may also
increase the spread of the pathogen, although it is cur-
rently unknown how much of an e¡ect hyaluronidase is
likely to have on such proliferation. Alternatively, the
clostridial hyaluronidase may degrade hyaluronate cell
surface coatings, thereby allowing direct contact between
the bacterium and speci¢c receptors on the cell surface.
Hyaluronidase production by oral pathogens belonging
to Peptostreptococcus sp. may play a role in the patho-
genesis of periodontal disease [17]. The ability to hydro-
lyze the ground substance of gingival tissue may lead to
periodontal destruction by enabling the bacteria to spread
to the roots of the residing teeth. Increased permeability of
the gingiva connective tissue may increase spread of bac-
terial toxins causing even more damage. Damage from the
host immune system due to exposure of antigenic determi-
nants, normally hidden, following partial breakdown of
the ground substance may cause additional damage.
Two important veterinary pathogens, S. uberis and
S. dysgalactiae, capable of causing mastitis have been
shown to produce hyaluronidase [9,10,30]. S. dysgalactiae
hyaluronidase, along with ¢brinolysin, may have an im-
portant role in promoting dissemination of the producing
organism into host tissue [9]. The enzyme from S. uberis
has been suggested to play a role in the spread of infec-
tion, although no evidence is available [31]. One interest-
ing observation indicated that S. uberis hyaluronidase is
able to inhibit proliferation of a mammary epithelial cell
line [30], suggesting that proliferation could be inhibited
by bacterial virulence factors in vivo during di¡erentiation
and growth of mammary tissue.
S. pneumoniae causes a number of di¡erent infections,
including meningitis and pneumonia. During infections,
the hyaluronidase may function as a spreading factor,
while the pneumolysin acts as a toxin. The sequence of
the gene suggests that pneumococcal hyaluronidase is cy-
toplasmic, released only when the pneumolysin causes lysis
of the pneumococci [7]. It is possible that release of hyal-
uronidase following cell lysis aids in the spread of the
toxin from the infection site. Studies on strains of S. pneu-
moniae isolated from patients show that all strains isolated
FEMSLE 9241 3-2-00
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from meningitis patients were hyaluronidase-positive,
while only 15% of strains isolated from healthy patients
produced the enzyme [32]. These authors also found that
strains lacking or producing low levels of hyaluronidase
produced brain infections only when inoculated with exog-
enous hyaluronidase. Such studies suggest a signi¢cant
role for the enzyme in bacterial growth or spread. Re-
cently, using signature-tagged mutagenesis, the in vivo
role of hyaluronidase in S. pneumoniae infections of mice
was investigated [33]. These studies provide evidence that
the hyaluronidase has a role in pneumonia, but little e¡ect
in septicemia. Such results indicate that the enzyme plays a
role in adhesion or colonization rather than survival in the
bloodstream; not surprising considering the location of
hyaluronate in body tissues.
Group A streptococci appear to have a `con£ict of in-
terest' with regard to their production of hyaluronidase.
These streptococci produce an anti-phagocytic capsule of
which the sole component is hyaluronate. It therefore
seems reasonable to hypothesize that the hyaluronidase
produced is going to deplete this protective capsule leaving
the organisms potentially susceptible to phagocytosis, as
the capsule is susceptible to degradation by the hyaluroni-
dase. However, continued production of hyaluronidase
establishes a means for the organism to degrade host con-
nective tissues allowing for bacterial spread. Perhaps other
anti-phagocytic factors such as M-protein provide su¤-
cient protection for S. pyogenes during hyaluronidase pro-
duction. A similar argument may be made for the role of
hyaluronidase production in S. uberis, which also produ-
ces a hyaluronate containing anti-phagocytic capsule [31].
Some strains of S. pyogenes show an acapsular pheno-
type, while encapsulated strains often lose their capsule
when entering or during the stationary phase of growth.
One possible explanation for this would be breakdown of
the hyaluronate due to hyaluronidase activity. However,
by looking at the transcript of the has operon, it has been
suggested that the unencapsulated phenotype was not due
to production of hyaluronidase, but due to loss of mRNA
transcript [34]. This conclusion was in part based on the
inability to detect hyaluronidase activity in these strains in
vitro. Although hyaluronidase is often reported as a
spreading factor in group A streptococci, less than 25%
of strains tested actually produce hyaluronidase in vitro
[18]. While few strains produce demonstrable hyaluroni-
dase in vitro, anti-hyaluronidase antibodies are often
present following streptococcal infections [35]. An impor-
tant aspect that needs examination is whether strains that
do not produce hyaluronidase in vitro may produce it in
vivo. Because of this, the regulatory relationship between
hyaluronidase and the hyaluronic acid capsule still re-
mains to be determined. It seems possible that in vitro
loss of capsule due to transcriptional regulation [34] may
only be part of the story. What occurs in those strains in
which the capsule and hyaluronidase are produced in
vivo? This question still needs to be addressed. The de-
struction of hyaluronate in connective tissues could poten-
tially result in the tissue damage seen in some streptococ-
cal infections, as well as allowing for dissemination of
toxins.
Some S. pyogenes exhibit two distinct hyaluronidases,
an extracellular hyaluronidase and a bacteriophage hyal-
uronidase [18]. Hyaluronidase associated with streptococ-
cal bacteriophages may allow phages possessing such en-
zymes to gain access to appropriate bacterial cell
receptors. Halperin et al. [36] report ¢nding antibodies
to streptococcal bacteriophage hyaluronidase following
streptococcal infections, indicating that the host was ex-
posed to the bacteriophage enzyme. This most likely oc-
curs following cell lysis and release of the phage particles.
It appears unlikely that the hyaluronidase plays a signi¢-
cant role in streptococcal disease, since the bacteriophage-
encoded enzyme is not secreted from the cell [18], although
an indirect role may be envisioned. The enzyme, some of
which is not associated with phage particles, may degrade
the hyaluronate, allowing for dissemination of the phage-
encoded erythrogenic toxin which is responsible, at least in
part, for the rash of scarlet fever. The hyaluronidase im-
portant in toxin spread, phage or bacterial, remains un-
determined.
Hyaluronate plays important roles in immune system
functions [3]. One possible role for the hyaluronidases of
pathogenic organisms may be the breakdown of hyaluron-
ate leading to modulation of the immune system, poten-
tially making a more `bacteria-friendly environment'. Such
a role has been postulated for the group B streptococcal
hyaluronidase, although no evidence is yet available [37].
Group B streptococcal infections may be enhanced by the
ability of hyaluronidase to degrade hyaluronate on cell
surfaces and in tissues. A role for the hyaluronidase in
pneumonia associated with some group B streptococcal
infections may be the result of increased tissue permeabil-
ity following exposure to hyaluronidase [37].
5. Outlook
Kreil [1] described hyaluronidases as a group of ne-
glected enzymes. Since this description, much has been
accomplished in the study of bacterial hyaluronidases,
but more information is necessary to answer important
questions regarding the role of these enzymes in bacterial
pathogenesis. Such questions apply equally to both human
pathogens (e.g. S. pneumoniae and S. aureus) and animal
pathogens (e.g. S. uberis and S. dysgalactiae). Sequence
information on the hyaluronidase genes from many impor-
tant pathogens still must be elucidated. With the increas-
ing number of pathogens for which chromosomal sequenc-
ing is currently underway, one aspect to be explored is
whether some of these pathogens produce, or have the
ability to produce, hyaluronidase. Sequence information
may be used as a guide to look for these enzymes in
FEMSLE 9241 3-2-00
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organisms for which such activity has not previously been
associated. With this information in hand, it should be
possible to design experiments to determine if the enzyme
is only produced under certain in vivo conditions. This
knowledge may be particularly bene¢cial in understanding
disease pathogenesis.
While sequence information provides important infor-
mation, in vitro studies need to be paired with in vivo
analysis. Just what role does the hyaluronidase have for
an organism? Is hyaluronidase involved in spread, or is it
a means of obtaining nutrients? Perhaps these two roles
are not mutually exclusive; organisms may use the enzyme
to spread, and in so doing release nutrients useful for
bacterial proliferation. How does the organism determine
when to produce hyaluronidase, or is it a constitutively
expressed enzyme? Some of the enzymes are upregulated
in the presence of the substrate, suggestive of a mechanism
whereby the cell displays some environmental recognition.
Many virulence factors are regulated in such a manner,
but the factor(s) responsible for turning genes on or o¡
are often unknown.
Another important issue to be addressed is the ability to
modulate the immune system. For pathogenic microorgan-
isms, the ability to avoid being killed by the host defenses
is obvious, but how the organism achieves this is often
poorly understood. Do bacterial hyaluronidases enhance
or inhibit the host immune response to a bacterial infec-
tion?
With the current tools available in molecular biology,
many of these questions can begin to be approached, but
they cannot be fully answered without in vivo models. In
vivo, we must look at di¡erent aspects, not limiting our-
selves to just one component of the response. Survival and
growth of the organism, dissemination both of organisms
and toxins, tissue destruction and immune modulation
may all play a role in pathogenesis of hyaluronidase pro-
ducing organisms. If we examine only one point, we may
miss the overall picture; only by examining all the di¡er-
ent aspects will a full understanding for the role of this
enzyme be forthcoming. Beyond the need to answer such
basic questions, a potential bene¢t also exists; understand-
ing the regulation and role in disease may lead to drugs
e¡ective in preventing or decreasing spread of infections or
toxins. Let us not neglect this important group of enzymes
any longer.
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